Smartlens, Inc. Closes $6.1M Series A led by Ambit Health Ventures with investments from prominent institutions and Stanford University

MOUNTAIN VIEW, Calif., July 11, 2023 /PRNewswire/ — Smartlens, Inc., a clinical-stage ophthalmic technology company, has closed an oversubscribed $6.1M Series A equity financing round to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring…

Click here to view original post